Cadila Healthcare informs about quarterly statement on investor complaints

06 Apr 2016 Evaluate

Cadila Healthcare has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

876.90 -4.20 (-0.48%)
20-Jan-2026 12:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1638.00
Dr. Reddys Lab 1185.20
Cipla 1378.40
Zydus Lifesciences 876.90
Lupin 2163.55
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×